Literature DB >> 25687909

Targeted therapies: Drug addiction revealed in BRAF and MEK inhibitor-resistant melanoma cells.

Peter Sidaway.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25687909     DOI: 10.1038/nrclinonc.2015.28

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addiction.

Authors:  Gatien Moriceau; Willy Hugo; Aayoung Hong; Hubing Shi; Xiangju Kong; Clarissa C Yu; Richard C Koya; Ahmed A Samatar; Negar Khanlou; Jonathan Braun; Kathleen Ruchalski; Heike Seifert; James Larkin; Kimberly B Dahlman; Douglas B Johnson; Alain Algazi; Jeffrey A Sosman; Antoni Ribas; Roger S Lo
Journal:  Cancer Cell       Date:  2015-01-15       Impact factor: 31.743

  1 in total
  1 in total

Review 1.  Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.

Authors:  Anna E Kersh; Maiko Sasaki; Lee A Cooper; Haydn T Kissick; Brian P Pollack
Journal:  Front Pharmacol       Date:  2016-09-26       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.